4BIO Capital Overview

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. The firm aims to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, 4BIO Capital seeks opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals, including Nature, The Lancet, Cell, and the New England Journal of Medicine. This expertise provides 4BIO with an unrivaled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.

Is 4BIO Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with 4BIO Capital, along with a list of other relevant VCs, is available on Hopohopo.io.